{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:00:09Z","timestamp":1792206009934,"version":"4.4.0"},"reference-count":21,"publisher":"BMJ","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.m3956","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T14:30:18Z","timestamp":1602772218000},"page":"m3956","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Warfarin in patients with mechanical heart valves"],"prefix":"10.1136","author":[{"given":"Fiona","family":"Catterall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul RJ","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Isles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"2020101507300755000_371.oct15_6.m3956.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"2020101507300755000_371.oct15_6.m3956.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.03.011"},{"key":"2020101507300755000_371.oct15_6.m3956.3","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S16420"},{"key":"2020101507300755000_371.oct15_6.m3956.4","unstructured":"National Institute for Health and Care Excellence Treatment Summary. Oral anticoagulants. https:\/\/bnf.nice.org.uk\/treatment-summary\/oral-anticoagulants.html"},{"key":"2020101507300755000_371.oct15_6.m3956.5","unstructured":"National Institute for Health and Care Excellence Clinical Knowledge Summaries. Anticoagulation\u2014oral. Scenario: warfarin. 2020. https:\/\/cks.nice.org.uk\/topics\/anticoagulation-oral\/management\/warfarin\/"},{"key":"2020101507300755000_371.oct15_6.m3956.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.2.635"},{"key":"2020101507300755000_371.oct15_6.m3956.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035612"},{"key":"2020101507300755000_371.oct15_6.m3956.8","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v3.i11.351"},{"key":"2020101507300755000_371.oct15_6.m3956.9","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v4.i3.54"},{"key":"2020101507300755000_371.oct15_6.m3956.10","unstructured":"Madler C, Lewis S, Edwards A. von Oppell U on behalf of the Aneurin Bevan University Health Board. Anticoagulation in patients with heart valve replacements: Guideline for primary and secondary care. http:\/\/www.wales.nhs.uk\/sites3\/Documents\/814\/ABUHB_Clinical_0780%20AnticoagulationForHeartValveReplacementsMarch2019.pdf"},{"key":"2020101507300755000_371.oct15_6.m3956.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.038"},{"key":"2020101507300755000_371.oct15_6.m3956.12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.041105"},{"key":"2020101507300755000_371.oct15_6.m3956.13","unstructured":"Warfarin. Patient information. 2020. www.nhsinform.scot\/types-of-medicine\/warfarin"},{"key":"2020101507300755000_371.oct15_6.m3956.14","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.5.3.433"},{"key":"2020101507300755000_371.oct15_6.m3956.15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003464.pub2"},{"key":"2020101507300755000_371.oct15_6.m3956.16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jtcvs.2018.06.089","article-title":"Management of anticoagulation in patients with mechanical heart valves undergoing noncardiac surgical procedures","volume":"158","author":"Tan","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2020101507300755000_371.oct15_6.m3956.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615"},{"key":"2020101507300755000_371.oct15_6.m3956.18","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-018-0249-5"},{"key":"2020101507300755000_371.oct15_6.m3956.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.06.015"},{"key":"2020101507300755000_371.oct15_6.m3956.20","unstructured":"National Institute for Health and Care Excellence Costing Report: atrial fibrillation. Implementing the NICE guideline on atrial fibrillation (CG180). 2014. https:\/\/www.nice.org.uk\/guidance\/cg180\/resources\/costing-report-pdf-243730909"},{"key":"2020101507300755000_371.oct15_6.m3956.21","unstructured":"SIGN129. Antithrombotics: indications and management. Edinburgh: SIGN; 2013. https:\/\/www.sign.ac.uk\/our-guidelines\/antithrombotics-indications-and-management\/"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.m3956","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.m3956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T14:31:45Z","timestamp":1602772305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.m3956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":21,"alternative-id":["10.1136\/bmj.m3956"],"URL":"https:\/\/doi.org\/10.1136\/bmj.m3956","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}